Tokyo, Japan

Norimasa Mikata

This inventor holds 1 USPTO granted patent. Top assignee: Daiichi Pharmaceutical Co., Ltd.. Active years: 1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Norimasa Mikata. Retrieved from https://idiyas.com/inventor/norimasa-mikata

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Norimasa Mikata: Innovator in Antimicrobial Compounds

Introduction

Norimasa Mikata is a distinguished inventor based in Tokyo, Japan. He has made significant contributions to the field of antimicrobial compounds, showcasing his expertise through innovative patent applications. His work is particularly focused on the selective crystallization of complex chemical compounds.

Latest Patents

Mikata holds a patent for a method of selectively obtaining various hydrates of a specific antimicrobial compound. The patent, titled "Crystals of antimicrobial compound," details a process that involves treating the compound in an aqueous solvent or recrystallizing it from water. This innovative method allows for the efficient production of different hydrate forms, which can be crucial for pharmaceutical applications.

Career Highlights

Throughout his career, Norimasa Mikata has been associated with Daiichi Pharmaceutical Co., Ltd., where he has contributed to the development of new antimicrobial agents. His work has been instrumental in advancing the understanding and application of these compounds in medicine.

Collaborations

Mikata has collaborated with notable colleagues, including Youichi Kimura and Katsuhiro Kawakami. These partnerships have fostered a collaborative environment that enhances research and innovation in the field of pharmaceuticals.

Conclusion

Norimasa Mikata's contributions to the field of antimicrobial compounds highlight his innovative spirit and dedication to advancing pharmaceutical science. His patent work and collaborations reflect a commitment to improving health outcomes through scientific discovery.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…